Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
196 participants
OBSERVATIONAL
2019-05-16
2021-12-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?
NCT02812784
Nephroprotection in Severe Trauma Patients With Kidney Stress
NCT06834633
Study of the Incidence and Prognosis of Intrahospital Acute Kidney Injury
NCT06697730
Acute Kidney Injury in Severe Trauma
NCT03433079
Non-recovery of Kidney Function After AKI
NCT05014022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severe traumatized patients
Severe traumatized patients with an Index Severity Score (ISS) ≥ 15 admitted to the trauma center of Edouard Herriot Hospital.
Nephrocheck test
Nephrocheck® measurement on urine sample at different timepoints.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nephrocheck test
Nephrocheck® measurement on urine sample at different timepoints.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* trauma patients with ISS ≥15
* patient admitted to the resuscitation bay of Edouard Herriot Hospital
Exclusion Criteria
* opposition of the patient (or a trusted person) to participate
* pregnant or lactating woman
* age \<18 years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Violette Zorio
Role: PRINCIPAL_INVESTIGATOR
Intensive Care Unit, Pavillon H - Réanimation chirurgicale. Edouard Herriot hospital 5 place d'Arsonval - 69003 Lyon FRANCE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Edouard Herriot
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL18_0903
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.